Table of Contents
Page
1
Key Points
2
Diagnosis
2 Figure 1. Acute Coronary Syndromes
4 Figure 2. GRACE Risk Model Nomogram
5 Table 1. TIMI Risk Score for NSTE-ACS
Table 2. Clinical Assessment and Initial Evaluation
Table 3. ED or Outpatient Facility Presentation
6 Table 4. Prognosis—Early Risk Stratification
7 Table 5. Cardiac Biomarkers and the Universal Definition of MI
8
Treatment
8 Table 6. Standard Medical Therapies
9 Table 7. Inhibitors of the Renin-Angiotensin-Aldosterone System
10 Table 8. Initial Antiplatelet/Anticoagulant Therapy in Patients
With Definite or Likely NSTE-ACS
11 Table 9. Early Invasive and Ischemia-Guided Strategies
12 Figure 3. Algorithm for Management of Patients With Definite or
Likely NSTE-ACS
14 Table 10. Risk Stratification Before Discharge for Patients With
an Ischemia-Guided Strategy of NSTE-ACS
14 Table 11. Myocardial Revascularization
17 Table 12. Timing of Urgent CABG in Patients With NSTE-ACS in
Relation to Use of Antiplatelet Agents
Table 13. Discharge From the ED or Chest Pain Unit
18 Table 14. Factors Associated With Appropriate Selection of Early
Invasive Strategy or Ischemia-Guided Strategy in Patients With
NSTE-ACS
19 Table 15. Dosing of Parenteral Anticoagulants During PCI
20 Table 16. Late Hospital Care, Hospital Discharge, and
Posthospital Discharge Care
23 Table 17. Quality of Care and Outcomes for ACS—Use of
Performance Measures and Registries
24 Table 18. Special Patient Groups
28
COR and LOE
